Found: 6
Select item for more details and to access through your institution.
Ten‐year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B virus infection.
- Published in:
- Liver International, 2019, v. 39, n. 10, p. 1868, doi. 10.1111/liv.14155
- By:
- Publication type:
- Article
Treatment with tenofovir disoproxil fumarate or entecavir in chronic hepatitis B virus‐infected patients with renal impairment: results from a 7‐year, multicentre retrospective cohort study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 3, p. 500, doi. 10.1111/apt.15901
- By:
- Publication type:
- Article
Hepatitis B Virus Lacks Immune Activating Capacity, but Actively Inhibits Plasmacytoid Dendritic Cell Function.
- Published in:
- PLoS ONE, 2011, v. 6, n. 1, p. 1, doi. 10.1371/journal.pone.0015324
- By:
- Publication type:
- Article
Hepatitis B virus surface antigen impairs myeloid dendritic cell function: a possible immune escape mechanism of hepatitis B virus.
- Published in:
- Immunology, 2009, v. 126, n. 2, p. 280, doi. 10.1111/j.1365-2567.2008.02896.x
- By:
- Publication type:
- Article
Kupffer cells interact with hepatitis B surface antigen in vivo and in vitro, leading to proinflammatory cytokine production and natural killer cell function.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
Kupffer Cells Interact With Hepatitis B Surface Antigen In Vivo and In Vitro, Leading to Proinflammatory Cytokine Production and Natural Killer Cell Function.
- Published in:
- Journal of Infectious Diseases, 2015, v. 211, n. 8, p. 1268, doi. 10.1093/infdis/jiu599
- By:
- Publication type:
- Article